Sign In
Buy GWPH
$218.96
+0 (+0%)
At Close: May 27, 2022
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether GW Pharmaceuticals plc (NASDAQ: GWPH) and its board of directors violated the federal securitie
Cannabis Watch: Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits
01:22pm, Wednesday, 03'rd Feb 2021
Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to win U.S. regulatory approval for a cannabis-based drug, a move that's expected to boost inve
Pot Stocks Are Wednesday's Big Stock Market Winners. Will They Disappoint Shareholders in the End?
12:18pm, Wednesday, 03'rd Feb 2021
In a quiet market, marijuana companies stood out.
GW PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GWPH and Encourages Investors to Contact the Firm
12:15pm, Wednesday, 03'rd Feb 2021
NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of GW Pharmac
GWPH Stock: 12 Things to Know About the GW Pharma-Jazz Pharma Deal
11:35am, Wednesday, 03'rd Feb 2021
GW Pharmaceuticals (GWPH) stock is soaring higher on Wednesday following news that Jazz Pharmaceuticals (JAZZ) is acquiring the company. The post GWPH Stock: 12 Things to Know About the GW Pharma-Jazz
Jazz Pharma adds cannabis-based drug in $7.2 billion deal for GW Pharma
11:27am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals Plc said on Wednesday it would buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding a cannabis-based epilepsy treatment.
Why GW Pharmaceuticals Stock Is Skyrocketing Today
11:10am, Wednesday, 03'rd Feb 2021
Investors cheered an unexpected acquisition of the cannabinoid-focused biotech.
Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion
10:03am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals said on Wednesday it would buy GW Pharmaceuticals in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding cannabis-based epilepsy treatment. CNBC's Ji
Cannabis-Derived Drug Maker GW Pharma Acquired by Jazz Pharma for $7.2 Billion
10:02am, Wednesday, 03'rd Feb 2021
Dublin-based Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) announced Wednesday morning that it has agreed to acquire London-based GW Pharmaceuticals PLC (NASDAQ: GWPH) for $220 per American depositary share
CBD Drug Makers, Medical Cannabis Stocks Rally On GW Pharma's Big Buyout
09:25am, Wednesday, 03'rd Feb 2021
Medical cannabis stocks and stocks of cannabinoid drug companies are rallying big time Wednesday, the catalyst being a multi-billion-dollar buyout in the space.
Jazz Pharmaceuticals buys GW Pharma for $7.2 billion
08:46am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share. CNBC's Becky Quick reports.
GWPH Stock Price Increases Over 40% Pre-Market: Why It Happened
08:34am, Wednesday, 03'rd Feb 2021
The stock price of GW Pharmaceuticals PLC (NASDAQ: GWPH) is trading at over 40% pre-market today as of 8:26 AM ET. This is why it happened.
Jazz Pharmaceuticals to acquire GW Pharma for $7.2 billion in cash and stock
07:46am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals Plc said Wednesday it has agreed to acquire GW Pharmaceuticals Plc in a cash-and-stock deal valued at $7.2 billion. Under the terms of the deal, Jazz Pharma will pay $200 per shar
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
07:30am, Wednesday, 03'rd Feb 2021
DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement
1 Overlooked Marijuana Stock to Buy for 2021
10:00am, Sunday, 31'st Jan 2021
It's a bit of an offbeat company operating in the sector.
